MedTrace Logo

The Effect of Grape Seed Extract on Blood Pressure in People With Pre-Hypertension

NCT00979732 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2021-02-11

Study results available
· View outcomes & findings →

Summary

In this research study, the investigators are interested in learning how extracts from grape seeds can help those individuals with high blood pressure. The investigators also hope to learn how grape seed extract effects your blood and cell functions.

The grape seed extract the investigators will use in the study will be provided either in a beverage or a capsule form and is currently available on the market. This study is also using a placebo; therefore the treatment subjects receive may or may not contain the grape seed extract.

The purpose of this study is to determine if the grape seed extract (GSE) will lower blood pressure in people with slightly high blood pressure (Pre-Hypertension).

Conditions

Interventions

DIETARY_SUPPLEMENT

grape seed extract

grape seed extract 150 mg twice a day (BID) in beverage or capsule form

DIETARY_SUPPLEMENT

grape seed extract placebo

grape seed extract 150 mg twice a day (BID) in beverage or capsule form

Sponsors & Collaborators

  • Polyphenolics, Inc.

    collaborator INDUSTRY

  • Clinical Nutrition Research Center, Illinois Institute of Technology

    lead INDUSTRY

Principal Investigators

  • Britt Burton-Freeman, PhD · Clinical Nutrition Research Center, Illinois Institute of Technology

  • Indika Edirisinghe, PhD · Clinical Nutrition Research Center, Illinois Institute of Technology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-11-15
Primary Completion
2014-10-15
Completion
2014-10-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00979732 on ClinicalTrials.gov